166 related articles for article (PubMed ID: 21194898)
1. A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial.
Mathew SJ; Vythilingam M; Murrough JW; Zarate CA; Feder A; Luckenbaugh DA; Kinkead B; Parides MK; Trist DG; Bani MS; Bettica PU; Ratti EM; Charney DS
Eur Neuropsychopharmacol; 2011 Mar; 21(3):221-9. PubMed ID: 21194898
[TBL] [Abstract][Full Text] [Related]
2. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial.
Tucker P; Zaninelli R; Yehuda R; Ruggiero L; Dillingham K; Pitts CD
J Clin Psychiatry; 2001 Nov; 62(11):860-8. PubMed ID: 11775045
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial.
Brady K; Pearlstein T; Asnis GM; Baker D; Rothbaum B; Sikes CR; Farfel GM
JAMA; 2000 Apr; 283(14):1837-44. PubMed ID: 10770145
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: study protocol for a randomized controlled trial.
Dunlop BW; Rothbaum BO; Binder EB; Duncan E; Harvey PD; Jovanovic T; Kelley ME; Kinkead B; Kutner M; Iosifescu DV; Mathew SJ; Neylan TC; Kilts CD; Nemeroff CB; Mayberg HS
Trials; 2014 Jun; 15():240. PubMed ID: 24950747
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled trial to assess the efficacy of topiramate in the treatment of post-traumatic stress disorder.
Mello MF; Yeh MS; Barbosa Neto J; Braga LL; Fiks JP; Mendes DD; Moriyama TS; Valente NL; Costa MC; Mattos P; Bressan RA; Andreoli SB; Mari JJ
BMC Psychiatry; 2009 May; 9():28. PubMed ID: 19480669
[TBL] [Abstract][Full Text] [Related]
6. Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo.
Furmark T; Appel L; Michelgård A; Wahlstedt K; Ahs F; Zancan S; Jacobsson E; Flyckt K; Grohp M; Bergström M; Pich EM; Nilsson LG; Bani M; Långström B; Fredrikson M
Biol Psychiatry; 2005 Jul; 58(2):132-42. PubMed ID: 16038684
[TBL] [Abstract][Full Text] [Related]
7. Fluoxetine versus placebo in posttraumatic stress disorder.
Martenyi F; Brown EB; Zhang H; Prakash A; Koke SC
J Clin Psychiatry; 2002 Mar; 63(3):199-206. PubMed ID: 11926718
[TBL] [Abstract][Full Text] [Related]
8. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial.
Mithoefer MC; Mithoefer AT; Feduccia AA; Jerome L; Wagner M; Wymer J; Holland J; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R
Lancet Psychiatry; 2018 Jun; 5(6):486-497. PubMed ID: 29728331
[TBL] [Abstract][Full Text] [Related]
9. Randomized Controlled Trial of Riluzole Augmentation for Posttraumatic Stress Disorder: Efficacy of a Glutamatergic Modulator for Antidepressant-Resistant Symptoms.
Spangler PT; West JC; Dempsey CL; Possemato K; Bartolanzo D; Aliaga P; Zarate C; Vythilingam M; Benedek DM
J Clin Psychiatry; 2020 Oct; 81(6):. PubMed ID: 33113596
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder.
Panahi Y; Moghaddam BR; Sahebkar A; Nazari MA; Beiraghdar F; Karami G; Saadat AR
Psychol Med; 2011 Oct; 41(10):2159-66. PubMed ID: 21349225
[TBL] [Abstract][Full Text] [Related]
11. A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder.
Feder A; Costi S; Rutter SB; Collins AB; Govindarajulu U; Jha MK; Horn SR; Kautz M; Corniquel M; Collins KA; Bevilacqua L; Glasgow AM; Brallier J; Pietrzak RH; Murrough JW; Charney DS
Am J Psychiatry; 2021 Feb; 178(2):193-202. PubMed ID: 33397139
[TBL] [Abstract][Full Text] [Related]
12. Antiemetic activity of the NK1 receptor antagonist GR205171 in the treatment of established postoperative nausea and vomiting after major gynaecological surgery.
Diemunsch P; Schoeffler P; Bryssine B; Cheli-Muller LE; Lees J; McQuade BA; Spraggs CF
Br J Anaesth; 1999 Feb; 82(2):274-6. PubMed ID: 10365008
[TBL] [Abstract][Full Text] [Related]
13. A Double-Blind, Placebo-Controlled Randomized Trial of Vilazodone in the Treatment of Posttraumatic Stress Disorder and Comorbid Depression.
Ramaswamy S; Driscoll D; Reist C; Smith LM; Albers LJ; Rose J; Nguyen L; Monga V; Doria R; Hollifield M
Prim Care Companion CNS Disord; 2017 Aug; 19(4):. PubMed ID: 28858440
[TBL] [Abstract][Full Text] [Related]
14. Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans.
Raskind MA; Peskind ER; Chow B; Harris C; Davis-Karim A; Holmes HA; Hart KL; McFall M; Mellman TA; Reist C; Romesser J; Rosenheck R; Shih MC; Stein MB; Swift R; Gleason T; Lu Y; Huang GD
N Engl J Med; 2018 Feb; 378(6):507-517. PubMed ID: 29414272
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study.
Tucker P; Trautman RP; Wyatt DB; Thompson J; Wu SC; Capece JA; Rosenthal NR
J Clin Psychiatry; 2007 Feb; 68(2):201-6. PubMed ID: 17335317
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the neurokinin-1 antagonist GR205171, alone and in combination with the 5-HT3 antagonist ondansetron, hyoscine and placebo in the prevention of motion-induced nausea in man.
Reid K; Palmer JL; Wright RJ; Clemes SA; Troakes C; Somal HS; House F; Stott JR
Br J Clin Pharmacol; 2000 Jul; 50(1):61-4. PubMed ID: 10886120
[TBL] [Abstract][Full Text] [Related]
17. Randomized, Placebo-Controlled Trial of the Angiotensin Receptor Antagonist Losartan for Posttraumatic Stress Disorder.
Stein MB; Jain S; Simon NM; West JC; Marvar PJ; Bui E; He F; Benedek DM; Cassano P; Griffith JL; Howlett J; Malgaroli M; Melaragno A; Seligowski AV; Shu IW; Song S; Szuhany K; Taylor CT; Ressler KJ;
Biol Psychiatry; 2021 Oct; 90(7):473-481. PubMed ID: 34275593
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.
Feder A; Parides MK; Murrough JW; Perez AM; Morgan JE; Saxena S; Kirkwood K; Aan Het Rot M; Lapidus KA; Wan LB; Iosifescu D; Charney DS
JAMA Psychiatry; 2014 Jun; 71(6):681-8. PubMed ID: 24740528
[TBL] [Abstract][Full Text] [Related]
19. A pooled analysis of gender and trauma-type effects on responsiveness to treatment of PTSD with venlafaxine extended release or placebo.
Rothbaum BO; Davidson JR; Stein DJ; Pedersen R; Musgnung J; Tian XW; Ahmed S; Baldwin DS
J Clin Psychiatry; 2008 Oct; 69(10):1529-39. PubMed ID: 19192435
[TBL] [Abstract][Full Text] [Related]
20. Secondary Prevention of Chronic PTSD by Early and Short-Term Administration of Escitalopram: A Prospective Randomized, Placebo-Controlled, Double-Blind Trial.
Zohar J; Fostick L; Juven-Wetzler A; Kaplan Z; Shalev H; Schreiber G; Miroshnik N; Shalev AY; Stein DJ; Seedat S; Suliman S; Klein E
J Clin Psychiatry; 2018; 79(2):. PubMed ID: 28703951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
